We are live on ! Find out more
MITO

Stealth BioTherapeutics Corp. ADS
MITO

Delisted

MITO was delisted on the 15th of November, 2022.

Back to rankings

19 hedge funds and large institutions have $334K invested in Stealth BioTherapeutics Corp. ADS in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 2

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

46% more funds holding

Funds holding: 13 → 19 (+6)

48% less capital invested

Capital invested by funds: $638K → $334K (-$304K)

Holders
19
Holders Change
+6
Holders Change %
+46.15%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
4
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$48.6K
2
VF
Virtu Financial
New York
+$34.5K
3
HighTower Advisors
HighTower Advisors
Illinois
+$19.3K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$18.6K
5
HF
HRT Financial
New York
+$12.5K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$11K
2
Citigroup
Citigroup
New York
-$4K
3
Morgan Stanley
Morgan Stanley
New York
-$4K
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$344

MITO Hedge Fund Activity: Q2 2022 in Review

19 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Stealth BioTherapeutics Corp. ADS (MITO) for Q2 2022, worth a combined $334K — down 48% from $638K a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new MITO positions and 2 closed out — a net gain of 6 holders — while 4 added to existing stakes and 2 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $48.6K. The largest seller was Renaissance Technologies, cutting an estimated $11K.

  • 19 institutional investors held Stealth BioTherapeutics Corp. ADS (MITO) as of Q2 2022, up from 13 in Q1 2022.
  • Funds reported $334K of Stealth BioTherapeutics Corp. ADS stock for Q2 2022, down 48% quarter-over-quarter.
  • 8 funds opened new Stealth BioTherapeutics Corp. ADS positions in Q2 2022 and 2 closed out, a net change of +6 holders.
  • The largest Stealth BioTherapeutics Corp. ADS buyer in Q2 2022 was Citadel Advisors, an estimated $48.6K added.
  • The largest Stealth BioTherapeutics Corp. ADS seller in Q2 2022 was Renaissance Technologies, an estimated $11K sold.

Based on aggregated 13F filings for Q2 2022.